4//SEC Filing
Barry James J 4
Accession 0000899243-18-012670
CIK 0001314102other
Filed
May 13, 8:00 PM ET
Accepted
May 14, 4:00 PM ET
Size
7.3 KB
Accession
0000899243-18-012670
Insider Transaction Report
Form 4
Barry James J
Director
Transactions
- Exercise/Conversion
Common Stock
2018-05-07+12,500→ 12,500 total - Exercise/Conversion
Deferred Stock Units
2018-05-07−12,500→ 0 total→ Common Stock (12,500 underlying)
Footnotes (2)
- [F1]Each deferred stock unit represents the right to receive one share of the common stock of EyePoint Pharmaceuticals, Inc.
- [F2]On December 15, 2017, the reporting person was granted 12,500 deferred stock units, which deferred stock units vested in full in connection with the effectiveness of Mr. Barry's resignation from the Board on May 7, 2018.
Documents
Issuer
EyePoint Pharmaceuticals, Inc.
CIK 0001314102
Entity typeother
Related Parties
1- filerCIK 0001541253
Filing Metadata
- Form type
- 4
- Filed
- May 13, 8:00 PM ET
- Accepted
- May 14, 4:00 PM ET
- Size
- 7.3 KB